ArticleBlood cancer discovery2022

CD20-Targeted Therapy Ablates De Novo Antibody Response to Vaccination but Spares Preestablished Immunity.

Tanaya Shree et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.